How effective is immunotherapy for Merkel cell carcinoma?

Merkel cell carcinoma is an uncommon, fast-growing skin cancer. Immunotherapy helps immune cells recognise cancer and may be considered when the disease has spread, returned or cannot be managed with local treatment alone. A response may mean that visible or internal tumours shrink, growth slows or symptoms ease. Some people respond for a sustained period, while others need a different approach.

The team assesses the skin, lymph nodes and any affected organs with examination and imaging. They also consider immune disorders, medicines, organ function and previous surgery or radiotherapy. A treatment decision is personal and should account for likely benefit, side effects and the time needed for monitoring.

Ask how the diagnosis was confirmed, where the cancer has been found and whether surgery or radiotherapy remains relevant. Tell the team about autoimmune disease, organ transplants, steroid use and all medicines. Keep a record of new skin changes, swollen glands, cough, diarrhoea, rash, fatigue or pain. Prompt reporting helps clinicians distinguish treatment effects from cancer symptoms or infection.

Seek emergency help for severe breathing difficulty, facial swelling, fainting, confusion, chest pain or uncontrolled bleeding. Contact the oncology team promptly for a rapidly enlarging lump, new neurological symptoms, persistent fever, severe diarrhoea, a spreading rash or sudden worsening weakness. Do not wait for the next scheduled infusion if a symptom is severe or rapidly changing.

Where is my Merkel cell carcinoma located and has it spread? What is the aim of immunotherapy in my case? How will you check the skin, lymph nodes and other areas? Could my autoimmune condition or medicines affect eligibility? Which symptoms need same-day advice, and what is the plan if the treatment does not control the cancer?